Background
The investigation of the mycobactericidal activity of disinfectants and antiseptics has been standardized for several years. The first European standard EN 14204 for testing the mycobactericidal activity of products used in the veterinary field was implemented by the CEN (European Committee for Standardization) in 2004. The standard EN 14563, dedicated to mycobactericidal products used in the medical area, was established in 2008. The laboratory research performed used mycobacterial strains derived from the American Type Culture Collection (ATCC), except for Mycobacterium tuberculosis, due to the risk of infection in the laboratory and the slow growth of microorganisms [1] . In addition, the mycobacteria that cause tuberculosis are classified by the US Centers for Disease Control and Prevention (CDC) in Atlanta as category C, and this pathogen can be used as a biological weapon.
According to World Health Organization (WHO), tuberculosis, HIV, and malaria are the most common infectious diseases in the world (one-third of the world population is infected with Mycobacterium tuberculosis) [2] . In this context, effective disinfection, in addition to regular immunization, is a significant method for the limitation of mycobacterial infections.
Mycobactericidal activity testing was performed in accordance with European standards (EN) based on the culture of mycobacteria, which means that the test results are known after 21 days. However, the use of the Mycobacterium terrae strain, which contains the gfp m 2+ gene, causes fluorescence of living mycobacteria cells and can reduce the detection time to 15 days [3, 4] .
There is growing interest among manufacturers of disinfectants and antiseptics in conducting tests of mycobactericidal activity in accordance with ENs, which will make the presence of high-quality products on the market possible.
The aim of this study was to evaluate the mycobactericidal activity against 2 mycobacterial species, Mycobacterium avium and Mycobacterium terrae, or the activity only against Mycobacterium tuberculosis, of selected chemical disinfectants and antiseptics used in the medical and veterinary areas in accordance with relevant European standards [5] [6] [7] .
The Department of Antibiotics and Microbiology at the National Medicines Institute, Warsaw, Poland, has investigated the antimicrobial effectiveness of antiseptic and disinfectant products for many years. Recently, we compared selected commercial mouthwash and disinfection products [8] . Our department is certified by the European Directorate for the Quality of Medicines (EDQM) for microbiological tests carried out in accordance with ISO/EN 17025 and possesses the accreditation of the Polish Centre for Accreditation (No. AB 774) for microbiological testing of disinfectants and antiseptics, according to several ENs.
Material and Methods

Products
These studies included 19 products submitted to the National Medicines Institute in Poland for the evaluation of mycobactericidal activity. These products contain active substances that belong to different chemical groups, including aldehydes, alcohols, amines, quaternary ammonium compounds, guanidine, phenols, and oxidizing compounds (Table 1) .
Standards
Investigations, according to the manufacturers' description of the products, were carried out in accordance with European standards, which also met the [7] .
Products recognized as mycobactericidal should be active against both Mycobacterium avium and Mycobacterium terrae mycobacterial species. Product activity against Mycobacterium tuberculosis is determined in accordance with the recommendations of the European Committee for Standardization (CEN), only to strain M. terrae.
The product meets the requirements of the PN-EN 14563: 2012 when after 60 min of contact time of the product and mycobacteria suspension in the appropriate temperature (10°C or 20°C), it demonstrates at least a decimal log reduction in counts of 4 (reduction ≥4 log cfu/mL) of both organisms (mycobactericidal activity) or only against M. terrae (tuberculocidal activity).
Depending on the application of the products, interfering substance were used: clean conditions were simulated by 0. 
Strains
In the studies performed according to the PN-EN 14348 and PN-EN 14563, 2 reference strains of mycobacteria -Mycobacterium avium ATCC 15769 and Mycobacterium terrae ATCC 15755 -were used. In tests performed according to PN-EN 14204, only the strain M. avium ATCC 15769 was used.
Results
The majority of products (17/18) for use in the medical field were tested in accordance with EN 14348. One product designed for use in the veterinary field was evaluated according to EN 14204. Both of these standards are to be tests of phase 2 step 1 (suspension method) in which the products are tested under simulated conditions by the introduction of inorganic loads (hard water to dilute the product) and organic loads (albumin, albumin + erythrocytes, or albumin + yeast extract). Only 4 studies were conducted in accordance with EN 14563 
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-the phase 2 step 2, in which a test suspension of mycobacteria in a solution of interfering substances was spread on a glass carrier (glass slides).
The majority of tested products (16 out of 19) showed mycobactericidal activity in accordance with the applicable standard under the selected conditions of the study (Tables 2 and 3) . Only 1 product, Desisoft Ytdesinfektion, did not present what was required by the appropriate standard of mycobactericidal activity in undiluted form, even when the longest contact time (60 min) was applied. The study was conducted at the request of the manufacturer; however, the mycobactericidal activity was not declared on the product's label. The other 2 products -Lysoformin Plus-Schaum and Virusolve + EDS -showed activity against only 1 of the mycobacteria strains -M. avium (Tables 2 and 3 ). Proper selection of the test conditions (concentration, contact time, interfering substance) allows for determination of the mycobactericidal activity in specific conditions of use. Table 3 presents the results of the activity of the product Virusolve + EDS, after 4 contact exposures of 5, 15, 30, and 60 min, examined in carrier test under simulated clean and dirty conditions. There was a significant increase in the activity of the product against M. avium, from about 2.3 log after 5 min to more than 4.9 log after 60 min. The extent of organic load had no effect on mycobactericidal activity. The prolongation of contact time of this product with M. terrae from 5 to 60 min did not cause appropriate activity (reduction minimum 4 log), although with increasing contact time, the product caused reduction of tested mycobacteria from a value of below 1.4 log to about 3.0 log. The manufacturer of the product (Virusolve + EDS) declared mycobactericidal activity at a 2.5% concentration after 5 min of contact time. The results in Table 3 show that this product, at a concentration of 2.5%, is active against M. avium only after 30 min of contact time, but in the case of M. terrae, the 4-log reduction was not achieved, even after 60 min of exposure to the agent.
Discussion
Mycobactericidal activity of disinfectants and antiseptics depends on chemical compositions, concentrations of use, durations of contact time, and organic loads.
Aldehydes, phenols, quaternary ammonium compounds, and polyalkylamines are commonly used as detergents/disinfectants in the disinfection procedure. Because of the toxicity of aldehydes and phenols, new disinfectant formulations are being developed. The antimicrobial activity of amine derivatives has been studied for some time.
Amine-based disinfectants have become quite popular for the disinfection of surgical instruments and other medical devices.
Korsolex
® AF (15.6% dodecyl-bis-propylene triamine and 5.1% lauryl propylene diamine) was studied by Hernandez et al. [9] . The mycobactericidal and tuberculocidal activities of Korsolex ® AF against M. tuberculosis H37 Rv ATCC 25618, Mycobacterium kansasii ATCC 12478, M. chelonae ATCC 35752, and a MAI (M. avium -M. intracellulare) clinical strain were determined using quantitative bacteria suspension and carrier tests. The effects of organic load and hard water were also considered. Korsolex ® AF had acceptable efficacy against several species of mycobacteria in quantitative suspension and carrier tests at a concentration of 2% with an exposure time of 30 min. One of the 4 strains -the MAI clinical strain -was the least sensitive: the reduction in number of mycobacteria was about 4.6 log, while for the other strains the reduction rate was more than 5 log.
Glutaraldehyde is widely used as the active ingredient in highlevel disinfectants for heat-sensitive, semi-critical medical instruments, including soft endoscopes or bronchoscopes, which may be contaminated with different strains of bacteria, including mycobacteria, after usage. Flexible fiber-optic bronchoscopy has become accepted as a safe tuberculosis diagnostic and therapeutic procedure and it is typically well tolerated by the patient. However, the transmission of Mycobacterium tuberculosis, atypical mycobacteria, and other pathogens between patients undergoing bronchoscopy has been reported due to improper cleaning and disinfection procedures [9] .
Miner et al. [10] demonstrated that products containing concentrations of ≤20% w/w isopropanol and ≤8% potassium acetate in combination with ≤3.5% w/w glutaraldehyde at alkaline pH values killed 6 log of mycobacteria -Mycobacterium bovis var BCG, M. terrae ATCC 15755, and glutaraldehyde-resistant M. chelonae var abscessus ATCC 14472 -within 10 min at 20°C.
In our study, products containing glutaraldehyde (Aldesan E, Aldizol, and Synsept AG) have also been found to be effective against mycobacteria (i.e., they meet the requirements of EN 14348).
Much work has been devoted to the study of the mycobactericidal activity of products containing ortho-phthalaldehyde (OPA), glutaraldehyde (GTA), and other dialdehydes.
Fraud et al. [11] showed high mycobactericidal activity of aldehydes (OPA) at 0.5% (v/v) unadjusted pH 6.5 and pH 8, under both clean and dirty conditions. Test organisms consisted of glutaraldehyde (GTA)-sensitive strains of Mycobacterium chelonae NCTC 946, M. abscessus NCTC 10882, two GTA-resistant M. chelonae strains, and M. terrae NCTC 10856 (a proposed M. tuberculosis surrogate). All mycobacterial reference strains used in the suspension test under clean conditions were very sensitive to 0.5% alkaline OPA, resulting in a log reduction factor of 5 after 1 min exposure or after 10 min with M. abscessus NTCC 10882. 
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In the carrier test, in which discs of polypropylene (the material of which endoscopes are constructed) were covered with biofilm formed from a mixture of mycobacteria with sodium alginate, a high degree of bacterial reduction was achieved (≥5 log) for a 0.5% w/v solution of OPA, but after a longer contact time (30-60 min) and only under clean conditions [12] .
Mycobactericidal activity of Cidex (2% glutaraldehyde) and Cidex OPA (0.55% ortho-phthalaldehyde) was evaluated with M. smegmatis ATCC 19420 and with clinical isolates of M. fortuitum, M. abscessus, and M. tuberculosis H37Rv (apart from the clinical strain of M. chelonae). Cidex and Cidex OPA were effective against tested organisms, showing greater than a 5-log reduction in colony-forming units (CFU) after 5 min of exposure under both clean and dirty conditions [13] .
In the past decade, high-level disinfectants based on glutaraldehyde have become widely used in disinfection because of their mycobactericidal activity. However, disinfection with glutaraldehyde has recently been of some concern because of its toxicity, skin and respiratory sensitizing of hospital staff, and the emergence of resistant mycobacteria. This agent also selects for strains of several microorganisms with a decreased susceptibility to 2% alkaline glutaraldehyde, such as Mycobacterium chelonae.
Several studies have been performed to assess possible alternatives to glutaraldehyde.
The in vitro and in vivo studies conducted by Hernandez et al. [14, 15] showed the equivalency of products for disinfection of bronchoscopes, containing 2% glutaraldehyde (Cidex) and 0.26% peracetic acid (Perasafe). Both preparations caused a reduction in the number of mycobacteria of more than 5 log after 20 to 30 min, under both clean and dirty conditions.
In our studies, products containing peracetic acid also caused high reduction ratios (over 6 log) of both mycobacterial strains of M. terrae and M. avium after 10 to 15 min of contact time in a study conducted in dirty conditions.
Chlorine dioxide may be an alternative to aldehydes in disinfection of soft endoscopes and other medical equipment.
In the carrier test according to the modified method of prEN 14563: 2005, Hernandez et al. [16] studied the activity of the product 'Tristel Sporicidal Wipes'. This system is composed of 2 components: a wipe that is saturated with a mixture of organic acids, preservatives, buffers, and corrosion inhibitors, and a bottle containing a sodium chlorite-based foam. Prior to testing, the wipes were prepared by squirting foam onto the wipe and then scrunching it by hand to mix the 2 components of the product to activate the disinfectant. The chlorine dioxide concentration in the activated wipe was 200 ppm. The results showed that the chlorine dioxide wipes were mycobactericidally active against M. avium ATCC 15769 with 30 s contact time with mechanical action and in 60 s without mechanical action, under both clean and dirty conditions.
In our suspension studies (EN 14348), chlorine-based disinfectant (Chlor-Clean) showed activity against both strains of mycobacteria M. avium and M. terrae, compatible with the standard. Increasing the chlorine concentration of use from 1000 ppm to 10 000 ppm, despite the changing conditions from clean to dirty at the same contact time; 15 min resulted in a significant increase in the degree of reduction of bacteria, from approximately 4 log to over 6 log.
An example of a different, new biocidal substance from the oxidizing agents group is 2-butanone peroxide, which is proposed 
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for use in antiseptic and disinfectant products dedicated for skin disinfection and for the disinfection of instruments and surfaces in a hospital environment. Garcia-de-Lomas et al. [17] tested the biocidal activity of different concentrations of 2-butanone peroxide against different microorganisms: bacteria, spores, fungi, viruses, and also mycobacteria, including M. terrae ATCC 15755. Mycobactericidal activity was assessed following the suspension method described in EN 14348. It showed a degree of reduction of approximately 7 log at a 0.5% solution, after 60 min of contact time at 20°C. Parallel toxicity tests were conducted. Toxicity assessment showed negative results in the acute dermal irritation test, acute eye irritation test, and acute oral toxicity test [17] . The results allow for the recognition of 2-butanone peroxide as an active ingredient suitable for use in the new formulation of antiseptics and disinfectants.
Taking into account the biocidal efficacy of disinfectants, as well as security to users and the environment and compatibility with disinfected materials, a new formulation based on hydrogen peroxide (accelerated hydrogen peroxide, AHD) was developed [18, 19] . It contains very low levels of certain foodgrade anionic and non-ionic surfactants, which act in synergy with hydrogen peroxide to produce the desired microbicidal activity. Omidbakhsh and Sattar [18] investigated the activity of such a product containing 0.5% hydrogen peroxide against mycobacteria: M. bovis, BCG strain and M. terrae ATCC 15755. The resulting degree of reduction after a contact time only 5 min at 20°C for these strains was over 6 log in the presence of 5% serum.
Our results confirmed the efficacy of products containing hydrogen peroxide (Synrol PAA10 and Synsept PAA) against mycobacteria M. avium and M. terrae. The complex composition of the products should also be considered, as they also include other active substances.
Disinfecting products that contain substances from the group of quaternary ammonium compounds do not exhibit effective biocidal activity against mycobacteria. Bello et al. [13] conducted studies with 2 disinfectants -Gerdex and K-ller -which both contain the quaternary ammonium compound dimethyl benzyl lauryl ammonium bromide in concentrations of 10% and 0.16%, respectively. Gerdex and K-ller caused only a 2-log cell reduction of M. tuberculosis H37Rv, M. abscessus, and M. chelonae, even after 60 min of contact time under both clean and dirty conditions. The products tested in our study (Lysoformin Plus-Schaum, OneMed Easydes and Synsept AG), in addition to quaternary ammonium compounds, also contain other active ingredients. Only the product Lysoformin Plus Schaum showed no reduction in accordance with EN 14348 of M. terrae cells, even under clean conditions after 15 min of contact time (<3.1 log), but in the case of a M. avium the degree of reduction was on the border of the requirements according to standard (approximately 4.1 log).
Conclusions
The tested products for disinfection and antisepsis contain active substances from different chemical groups: aldehydes, alcohols, quaternary ammonium compounds, phenolic compounds, and oxidizing agents. In most cases they showed mycobactericidal activity that complied with European standards. In the case of products that contain guanidines and amine compounds, the concentration of active ingredients used and the test conditions specified by the client that ordered the test did not show the mycobactericidal activity required by the standards. Prior to the introduction of the product to the market, it is important to establish the appropriate conditions for the use of the product, such as the concentration to use, contact time, and clean or dirty conditions.
